VCM
ADMA icon

Viewpoint Capital Management’s ADMA Biologics ADMA Stock Holding History

Viewpoint Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,416
Closed -$228K – 141
2024
Q2 		$228K Buy
20,416
+5,000
+32% +$41.9K 0.14% 97
2024
Q1 		$102K Buy
15,416
+2,416
+19% +$13.2K 0.06% 110
2023
Q4 		$58.8K Hold
13,000
– – 0.04% 112
2023
Q3 		$46.5K Hold
13,000
– – 0.04% 108
2023
Q2 		$48K Hold
13,000
– – 0.04% 109
2023
Q1 		$43K Hold
13,000
– – 0.04% 100
2022
Q4 		$50.4K Buy
+13,000
New +$40.1K 0.05% 98
2022
Q3 		– Sell
-13,000
Closed -$26K – 110
2022
Q2 		$26K Buy
+13,000
New +$25.6K 0.02% 103

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return